Lupin Secures Tentative Approval from FDA for Brimonidine Tartrate Ophthalmic Solution
Lupin has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Brimonidine Tartrate Ophthalmic Solution, 0.025 percent (OTC).
Minor Eye Irritations | 16/08/2024 | By Aishwarya | 221
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy